GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RVSB · Sep 30, 2024

RIVERVIEW BANCORP INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000939057-24-000317Bank
Sequential deposit growth60thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.46% · CORE · VALID

Net-income growth35thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-37.01% · CORE · VALID

Interest-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

6.46% · CORE · VALID

Cash and equivalents30thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$31.0M · CORE · VALID

Sequential loan growth65thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.54% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History58 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
-0.97%
Current
1.46%
Delta
2.44%
Earnings Growth Increased
Previous
-66.02%
Current
-37.01%
Delta
29.01%
Interest Income Growth Increased
Previous
3.17%
Current
6.46%
Delta
3.30%
Liquidity Increased
Previous
$27.8M
Current
$31.0M
Delta
$3.2M
Loan Growth Decreased
Previous
2.09%
Current
1.54%
Delta
-0.55%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.